Literature DB >> 9570555

Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma.

P Zhou1, G Miller, R A Seder.   

Abstract

Primary infection to Histoplasma capsulatum often results in a self-limited upper respiratory infection in humans; however, in immunocompromised hosts, disseminated infection can occur through reactivation of a previous infection. Since disseminated histoplasmosis has emerged as a difficult clinical entity to treat in individuals infected with HIV, it was of interest to study the mechanisms involved in maintaining an effective memory immune response. It has been previously shown in a murine model of disseminated histoplasmosis that IL-12, IFN-gamma, and TNF-alpha were important factors in mediating primary protection. To study whether these and other factors were involved in maintaining a protective immune response following secondary infection, normal C57BL/6 mice were first infected with a sublethal dose of H. capsulatum (1 x 10(5)) and then reinfected 3 wk later with a lethal dose of H. capsulatum (6 x 10(5)). Under these conditions, all mice developed an effective immune response with sterilizing immunity. Moreover, normal C57BL/6 mice treated with neutralizing Abs against either IL-12, TNF-alpha, or IFN-gamma, depleted of neutrophils or treated with aminoguanidine at the time of reinfection, maintained an effective immune response. The ability of animals to survive a secondary infection in the absence of IFN-gamma was verified by showing that IFN-gamma(-/-) mice previously immunized with H. capsulatum and treated with amphotericin B at the time of primary infection had prolonged survival following reinfection with a normally lethal dose. It was further shown that enhancement of TNF-alpha production in IFN-gamma(-/-) mice was the major mechanism by which these mice were effective in controlling secondary infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570555

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  CCR5 deficiency mitigates the deleterious effects of tumor necrosis factor α antagonism in murine histoplasmosis.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  J Infect Dis       Date:  2012-01-23       Impact factor: 5.226

2.  Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.

Authors:  Holly L Allen; George S Deepe
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

3.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

Review 4.  Immunosuppression related to collagen-vascular disease or its treatment.

Authors:  Carol Dukes Hamilton
Journal:  Proc Am Thorac Soc       Date:  2005

5.  CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.

Authors:  Carlos S Subauste; Matthew Wessendarp
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

6.  Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response.

Authors:  Mark R Scheckelhoff; George S Deepe
Journal:  J Infect Dis       Date:  2006-02-09       Impact factor: 5.226

7.  T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Infect Dis       Date:  2005-12-05       Impact factor: 5.226

8.  Tumour necrosis factor alpha contributes to protection against Giardia lamblia infection in mice.

Authors:  P Zhou; E Li; T Shea-Donohue; S M Singer
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

9.  Tumor necrosis factor-alpha antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.

Authors:  George S Deepe
Journal:  J Interferon Cytokine Res       Date:  2007-06       Impact factor: 2.607

Review 10.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.